journal article·2024-10-11

Amino Acid and Au(III) Self-Assembled Supramolecular Nanozymes for Antimicrobial Applications

Yunzhu Xu, Dahai Hou, Min Zhao, Tong Zhao, Yong Ma, Yafeng Zhang, Yang Guo, Weiwei Tao, Hui Wang

ACS Applied Nano Materials· Volume 7· Issue 19
Publisher page

Abstract

The construction of highly catalytic nanozymes that are composed of biomolecules remains a difficulty due to complicated synthesis methods and poor catalytic efficiencies. In this study, the authors fabricated noble metal ion supramolecular nanospheres (Fmoc-His-Au) through the combination of electrostatic adsorption and multifarious weak intermolecular force between AuCl 4 – and amphipathic histidine. The synthesis procedure is extremely simple and easy, and the noncovalent bond interactions between amphiphilic histidine and AuCl 4 – facilitated the constitution of supramolecular nanostructures and simultaneously stabilized the highly active AuCl 4 – center, which exhibited great peroxidase (POD)- and oxidase (OXD)-like capacities that could efficaciously transform the dissolved oxygen and H 2 O 2 to reactive oxygen species (ROS). In addition, this simple and innovative nanozyme displayed a preeminent antibacterial and wound healing performance both for Staphylococcus aureus and Escherichia coli bacteria in vitro and in vivo, with the bacteria inhibition percentage of over 98% for S. aureus and E. coli, and exhibited benign biocompatibility and low toxicity. This study paves the way for designing outstanding catalytic enzyme-like supramolecular nanostructures composed of simple amino acids and metal ions for wide nanomedical and pharmaceutical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China

School of Pharmacology, Nanjing University of Chinese Medicine, Nanjing 210046, China

Jiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi 214071, China

Jiangsu Collaborative Innovation Centre of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210046, China

Funding

Natural Science Foundation of Jiangsu Province · Jiangsu province · Jiangsu CM Clinical Innovation Center of Degenerative Bone and Joint Disease, Nanjing University of Chinese Medicine · Jiangsu Higher Education Institutions

References (53)

Show source-provided references
1. 10.1016/j.jiph.2020.07.00310.1016/j.jiph.2020.07.003 ↗
2. 10.1590/1806-9282.2021081210.1590/1806-9282.20210812 ↗
3. 10.7759/cureus.4571610.7759/cureus.45716 ↗
4. 10.1186/s12929-022-00806-110.1186/s12929-022-00806-1 ↗
5. 10.1007/s12275-023-00024-w10.1007/s12275-023-00024-w ↗
6. 10.1186/s12951-022-01295-y10.1186/s12951-022-01295-y ↗
7. 10.1007/s11051-019-4738-410.1007/s11051-019-4738-4 ↗
8. 10.1016/j.colsurfb.2020.11146510.1016/j.colsurfb.2020.111465 ↗
9. 10.1016/j.cclet.2022.10795110.1016/j.cclet.2022.107951 ↗
10. 10.1016/j.jcis.2021.08.05410.1016/j.jcis.2021.08.054 ↗
11. 10.7150/thno.7368110.7150/thno.73681 ↗
12. 10.1016/j.snb.2023.13420410.1016/j.snb.2023.134204 ↗
13. 10.1039/D2TB01365G10.1039/D2TB01365G ↗
14. 10.1002/cbic.20200012310.1002/cbic.202000123 ↗
15. 10.1016/j.msec.2020.11138210.1016/j.msec.2020.111382 ↗
16. 10.1038/s41467-017-00424-810.1038/s41467-017-00424-8 ↗
17. 10.1021/acsnano.0c0525510.1021/acsnano.0c05255 ↗
18. 10.1016/j.actbio.2022.05.04710.1016/j.actbio.2022.05.047 ↗
19. 10.1016/j.redox.2024.10321710.1016/j.redox.2024.103217 ↗
20. 10.1002/smll.20220568210.1002/smll.202205682 ↗
21. 10.1016/j.cej.2020.12724010.1016/j.cej.2020.127240 ↗
22. 10.1021/acsami.2c0511410.1021/acsami.2c05114 ↗
23. 10.1002/smll.20230104810.1002/smll.202301048 ↗
24. 10.1016/j.cej.2021.13400310.1016/j.cej.2021.134003 ↗
25. 10.1039/D3NR06042J10.1039/D3NR06042J ↗
26. 10.1038/s41467-022-28942-010.1038/s41467-022-28942-0 ↗
27. 10.1038/s41467-024-45668-310.1038/s41467-024-45668-3 ↗
28. 10.1021/acsami.3c1846310.1021/acsami.3c18463 ↗
29. 10.1039/D1NA00619C10.1039/D1NA00619C ↗
30. 10.1016/j.cej.2022.13531210.1016/j.cej.2022.135312 ↗
31. 10.1002/smll.20230109610.1002/smll.202301096 ↗
32. 10.1016/j.cej.2020.12498710.1016/j.cej.2020.124987 ↗
33. 10.1002/anie.20201000510.1002/anie.202010005 ↗
34. 10.1039/D2CS00675H10.1039/D2CS00675H ↗
35. 10.1002/smtd.20220170810.1002/smtd.202201708 ↗
36. 10.1016/j.cej.2021.12967410.1016/j.cej.2021.129674 ↗
37. 10.1002/chem.20210424710.1002/chem.202104247 ↗
38. 10.1002/smll.20190730910.1002/smll.201907309 ↗
39. 10.1002/smll.20220054810.1002/smll.202200548 ↗
40. 10.3390/atmos1306097010.3390/atmos13060970 ↗
41. 10.1002/advs.20230691110.1002/advs.202306911 ↗
42. 10.1039/D2NR02353A10.1039/D2NR02353A ↗
43. 10.1021/acscatal.3c0545410.1021/acscatal.3c05454 ↗
44. 10.1021/acs.langmuir.2c0048210.1021/acs.langmuir.2c00482 ↗
45. 10.1039/D3SC06845E10.1039/D3SC06845E ↗
46. 10.1002/adma.20220013910.1002/adma.202200139 ↗
47. 10.1016/j.snb.2024.13528010.1016/j.snb.2024.135280 ↗
48. 10.1021/acsami.0c1445110.1021/acsami.0c14451 ↗
49. 10.1002/adfm.20190549310.1002/adfm.201905493 ↗
50. 10.1016/j.jconrel.2024.01.06610.1016/j.jconrel.2024.01.066 ↗
51. 10.1016/j.cej.2024.14888810.1016/j.cej.2024.148888 ↗
52. 10.1016/j.cej.2021.12943110.1016/j.cej.2021.129431 ↗
53. 10.1186/s12951-023-02005-y10.1186/s12951-023-02005-y ↗